Modulation of Adenovirus-mediated Gene Transfer by Nitric Oxide

American Journal of Respiratory Cell and Molecular Biology

Volumn 16, Issue 5, 1997, Pages 501-509

  Haddad, Imad Y ^b   Sorscher, Eric J ^b   Garver Jr , Robert I ^b   Hong, Jeong ^b   Tzeng, Edith ^b   Matalon, Sadis ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE;

5,6,7,8-TETRAHYDROBIOPTERIN; 8 BROMO CYCLIC GMP; 8-BROMOCYCLIC GMP; ANTIOXIDANT; BETA GALACTOSIDASE; BIOPTERIN; CYCLIC GMP; DRUG DERIVATIVE; ENZYME INHIBITOR; LUCIFERASE; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PTERIDINE DERIVATIVE; PTERIN DERIVATIVE; SEPIAPTERIN; TETRAHYDROBIOPTERIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN 3T3; CELL SURVIVAL; DRUG ANTAGONISM; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; HUMAN ADENOVIRUS; IMMUNOLOGY; LUNG; METABOLISM; MOUSE; PHYSIOLOGY; REPORTER GENE; VIROLOGY;

3T3 CELLS; ADENOVIRUSES, HUMAN; ANIMALS; ANTIOXIDANTS; BETA-GALACTOSIDASE; BIOPTERIN; CELL SURVIVAL; CYCLIC GMP; ENZYME INHIBITORS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; LUCIFERASES; LUNG; MICE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; OMEGA-N-METHYLARGININE; PTERIDINES; PTERINS; TRANSFECTION;

EID: 0031132752     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.16.5.9160832     Document Type: Article

References (54)

1. Hubbard, R. C., M. A. Casolaro, M. Mitchell, S. E. Sellers, F. Arabia, M. A. Matthay, and R. G. Crystal. 1989. Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance. Proc. Natl. Acad. Sci. USA 86:680-684.
2. Mastrangeli, A., C. Danel, M. A. Rosenfeld, L. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J. P. Lecocq, and R. G. Crystal. 1993. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91:225-234.
3. Brigham, K. L., A. E. Canonico, B. O. Meyrick, H. Schreier, A. A. Stecenko, and J. T. Conary. 1994. Gene therapy for inflammatory diseases. Prog. Clin. Biol. Res. 388:361-365.
4. Knowles, M. R., K. W. Hohneker, Z. Zhou, J. C. Olsen, T. L. Noah, P. C. Hu, M. W. Leigh, J. F. Engelhardt, L. J. Edwards, and K. R. Jones. 1995. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis [see comments]. N. Engl. J. Med. 333:823-831.
5. Crystal, R. G., A. Jaffe, S. Brody, A. Mastrangeli, N. G. McElvaney, M. Rosenfeld, C. S. Chu, C. Danel, J. Hay, and T. Eissa. 1995. A phase I study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Hum. Gene Ther. 6:643-666.
6. Rosenfeld, M. A., G. Ronald, and R. G. Crystal. 1993. Gene therapy for pulmonary diseases. Pathol. Biol. (Paris) 41:677-680.
7. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
8. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
9. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
10. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:362-369.
11. Asano, K., C. B. Chee, B. Gaston, C. M. Lilly, C. Gerard, J. M. Drazen, and J. S. Stamler. 1994. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. USA 91:10089-10093.
12. Jain, B., I. Rubinstein, R. A. Robbins, and J. H. Sisson. 1995. TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium. Am. J. Physiol. 268:L911-L917.
13. Adler, K. B., B. M. Fischer, H. Li, N. H. Choe, and D. T. Wright. 1995. Hypersecretion of mucin in response to inflammatory mediators by guinea pig tracheal epithelial cells in vitro is blocked by inhibition of nitric oxide synthase. Am. J. Respir. Cell Mol. Biol. 13:526-530.
14. Gutierrez, H. H., B. R. Pitt, M. Schwarz, S. C. Watkins, C. Lowenstein, I. Caniggia, P. Chumley, and B. A. Freeman. 1995. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. Am. J. Physiol. 268:L501-L508.
15. Wizemann, T. M., C. R. Gardner, J. D. Laskin, S. Quinones, S. K. Durham, N. L. Goller, S. T. Ohnishi, and D. L. Laskin. 1994. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J. Leukoc. Biol. 56:759-768.
16. Fukushima, T., K. Sekizawa, M. Yamaya, S. Okinaga, M. Satoh, and H. Sasaki. 1995. Viral respiratory infection increases alveolar macrophage cytoplasmic motility in rats: role of NO. Am. J. Physiol. 268:L399-L406.
17. Haddad, I. Y., G. Pataki, P. Hu, C. Galliani, J. S. Beckman, and S. Matalon. 1994. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest 94:2407-2413.
18. Belvisi, M., P. J. Barnes, S. Larkin, M. Yacoub, S. Tadjkarimi, T. J. Williams, and J. A. Mitchell. 1995. Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur. J. Pharmacol. 283:255-258.
19. Mulligan, M. S., J. M. Hevel, M. A. Marietta, and P. A. Ward. 1991. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci. USA 88:6338-6342.
20. Berisha, H. I., H. Pakbaz, A. Absood, and S. I. Said. 1994. Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc. Natl. Acad. Sci. USA 91:7445-7449.
21. Heiss, L. N., J. R. Lancaster, Jr., J. A. Corbett, and W. E. Goldman. 1994. Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc. Natl. Acad. Sci. USA 91:267-270.
22. Kubes, P., M. Suzuki, and D. N. Granger. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651-4655.
23. Kavanagh, B. P., A. Mouchawar, J. Goldsmith, and R. G. Pearl. 1994. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J. Appl. Physiol. 76:1324-1329.
24. Haddad, I. Y., B. R. Pitt, and S. Matalon. 1996. Nitric oxide and lung injury. In Pulmonary Diseases and Disorders. A. P. Fishman, editor. McGraw-Hill, New York.
25. Mohr, S., J. S. Stamler, and B. Brune. 1994. Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett. 348:223-227.
26. Stamler, J. S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-936.
27. Felley-Bosco, E., S. Ambs, C. J. Lowenstein, L. K. Keefer, and C. C. Harris. 1994. Constitutive expression of inducible nitric oxide synthase in human bronchial epithelial cells induces c-fos and stimulates the cGMP pathway. Am. J. Respir. Cell Mol. Biol. 11:159-164.
28. Pilz, R. B., M. Suhasini, S. Idriss, J. L. Meinkoth, and G. R. Boss. 1995. Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 9:552-558.
29. Peng, H. B., P. Libby, and J. K. Liao. 1995. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270:14214-14219.
30. Kourembanas, S., L. P. McQuillan, G. K. Leung, and D. V. Faller. 1993. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92:99-104.
31. 4B promotes assembly of enzyme subunits into an active dimer. Proc. Natl. Acad. Sci. USA 92:11771-11775.
32. Herz, J. and R. D. Gerard. 1993. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA 90:2812-2816.
33. Goldsmith, K. T., D. T. Curiel, J. A. Engler, and R. I. Garver, Jr. 1994. Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells. Hum. Gene Ther. 5:1341-1348.
34. Haddad, I. Y., J. P. Crow, P. Hu, Y. Ye, J. Beckman, and S. Matalon. 1994. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am. J. Physiol. 267:L242-L249.
35. Erickson, J. R. and D. R. Morales. 1991. Clinical use of lactic dehydrogenase. N. Engl. J. Med. 265:478-182.
36. Zhu, S., I. Y. Haddad, and S. Matalon. 1996. Nitration of surfactant protein A (SP-A) tyrosine residues results in decreased mannose binding ability. Arch. Biochem. Biophys. (In press)
37. Croen, K. D. 1993. Evidence for an antiviral effect of nitric oxide: inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:2446-2452.
38. Karupiah, G., Q. W. Xie, R. M. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261:1445-1448.
39. Lander, H. M., P. Sehajpal, D. M. Levine, and A. Novogrodsky. 1993. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1509-1516.
40. Eigler, A., J. Moeller, and S. Endres. 1995. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J. Immunol. 154:4048-4054.
41. Persoons, J. H. A., K. Schornagel, F. F. H. Tilders, J. de Vente, F. Berkenbosch, and G. Kraal. 1996. Alveolar macrophages autoregulate IL-1 and IL-6 production by endogenous nitric oxide. Am. J. Respir. Cell Mol. Biol. 14:272-278.
42. van der Meide, P. H., M. C. de Labie, C. A. Botman, J. Aten, and J. J. Weening. 1995. Nitric oxide suppresses IFN-gamma production in the spleen of mercuric chloride-exposed brown Norway rats. Cell Immunol. 161:195-206.
43. Kroncke, K. D., K. Fehsel, T. Schmidt, F. T. Zenke, I. Dasting, J. R. Wesener, H. Bettermann, K. D. Breunig, and V. Kolb-Bachofen. 1994. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem. Biophys. Res. Commun. 200:1105-1110.
44. Lincoln, T. M., P. Komalavilas, and T. L. Cornwell. 1994. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 23:1141-1147.
45. Robbins, C. G., J. M. Davis, T. A. Merritt, J. D. Amirkhanian, N. Sahgal, F. C. Morin, III, and S. Horowitz. 1995. Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Am. J. Physiol. 269:L545-L550.
46. Matalon, S., V. DeMarco, I. Y. Haddad, C. Myles, J. W. Skimming, S. Schurch, S. Cheng, and S. Cassin. 1996. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 270:L273-L280.
47. Gustafsson, L. E., A. M. Leone, M. G. Persson, N. P. Wiklund, and S. Moncada. 1991. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun. 181:852-857.
48. Schedin, U., C. Frostell, M. G. Persson, J. Jakobsson, G. Andersson, and L. E. Gustafsson. 1995. Contribution from upper and lower airways to exhaled endogenous nitric oxide in humans. Acta Anaesthesiol. Scand. 39:327-332.
49. Alving, K., E. Weitzberg, and J. M. Lundberg. 1993. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 6:1368-1370.
50. Kharitonov, S. A., D. Yates, and P. J. Barnes. 1995. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur. Respir. J. 8:295-297.
51. Kharitonov, S. A., D. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes. 1994. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135.
52. Trapnell, B. C., S. Yei, N. Mittereder, K. Tang, L. Weaver, and C. M. Gaithersburg. 1995. Adenovirus-mediated gene transfer to the lung is significantly enhanced by concurrent, brief, intermittent dexamethasone administration. Am. J. Respir. Crit. Care Med. 151:124. (Abstr.)
53. Szabo, C., C. Thiemermann, C. C. Wu, M. Perretti, and J. R. Vane. 1994. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc. Natl. Acad. Sci. USA 91:271-275.
54. Yates, D. H., S. A. Kharitonov, R. A. Robbins, P. S. Thomas, and P. J. Barnes. 1995. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 152: 892-896.